The Uterine Adenosarcoma in a Young Woman Treated by TAH/BOS and Combined Adjuvant Therapy: A Case Report

  • Soodabeh Shahidsales
  • Marjaneh Farazestanian
  • Noorieh Sharifi‐Sistani
  • Sara Rasta
  • Seyed Alireza Javadinia
Keywords: Uterine adenosarcoma; Treatment; Adjuvant therapy

Abstract

We aimed to report a woman suffering from uterine adenosarcoma in the perimenopause period. The patient had undergone total abdominal hysterectomy (TAH) with bilateral salpingo-oophorectomy (BSO) and also received adjuvant chemotherapy and radiotherapy. Moreover, she was reported as disease-free with no evidence of recurrence or metastasis despite the existence of numerous risk factors such as deep myometrial invasion as well as sarcomatous overgrowth after one year of follow-up. The results obtained about this patient could highlight the role of adjuvant therapy in terms of managing treatments for patients suffering from MASO, especially in the presence of deep myometrial invasion and an advanced stage.

Published
2020-07-22
Section
Articles